Therapeutics

Surprise! Pharma says their “digital resources” are good for consumers

Sirensong Reliance on pharma-sponsored digital resources among online U.S. adults is significant. The research found “51% of online U.S. adults (ages 18+) use pharma-sponsored digital resources, such as condition and treatment information, disease management tools, doctor discussion guides, or mobile apps or websites.” This validates that the interactive information and tools produced by biopharma are […]

Posted in | | Leave a response

Impact of Anti-infective Drug Shortages [Article]

Clinical Infectious Disease (online January 19): Abstract Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to […]

Posted in | | Leave a response

The e-patient movement, panacea or barrier to care?

I haven’t really paid much attention to the e-patient movement, but recently it’s become a subject of interest. I Googled “epatient”, and here’s what I found: “e-Patients are health consumers who use the Internet to gather information about a medical condition of particular interest to them, and who use electronic communication tools in coping with […]

Posted in | | 2 Responses

Safety, privacy and UCSF Med Center’s failure to do the right thing

I am a UCSF School of Pharmacy alum. I consider UCSF Medical Center, along with many other people, to be one of the best medical centers in the country. And, UCSF Medical Center saved my mother’s life with a liver transplant earlier this year. However, I am frustrated with UCSF Medical Center this morning.

Posted in | | 1 Response

Medscape mobile acknowledges problem with iOS 5

Apparently some Medscape mobile users with iOS 5 have had some issues. Below is the content from an email I received earlier today. Not exactly sure what the problem is as the email didn’t actually say. I’d be leery of the application until the fix is applied, which according to the email will be sometime […]

Posted in , | | 1 Response

Fun with Lugol’s solution…not really

A recent ISMP Medication Safety Alert shared various errors that have occurred with Lugol’s solution over the ages. Lugol’s solution is a concentrated liquid form of potassium iodide and iodine known for its use in the treatment of hyperthyroidism. It’s also a dangerous drug because it’s typically dosed in drops, not mL’s. Anyway, the ISMP […]

Posted in | | 1 Response

National Influenza Vaccination Week December 4-10

Apparently National Influenza Vaccination Week (NIVW) is next week. Who knew? The CDC has additional information on NIVW here, and a whole lot more information on seasonal influenza (Flu) as well. Need to know more about types of influenza viruses? No problem, you can find that at the CDC site too. The most common form […]

Posted in | | Leave a response

Canada calls for national drug shortage registry [article]

The Canadian Pharmacist Association is looking for a way to track drug shortages. They would like to get drug manufactures and hospitals to participate in a national reporting system. It’s a great idea and one that I think could provide value.

Posted in | | Leave a response

Pharmacists impact on osteoporosis management (review article)

Pharmacists are pretty good at helping people with chronic medical conditions manage their medications, hence the term Medication Therapy Managment (MTM). You can find more information about MTM at the American Pharmacists Association (APhA) website. Anyway, I came across an article this morning that gives the results of a literature review “to examine the impact […]

Posted in | | Leave a response

Bacteria everywhere run scared as vancomycin gets new life

medGadget: “Scientists from the Scripps Research Institute have successfully reengineered vancomycin. They have reported their findings in the Journal of the American Chemical Society. This research could be a solution in the treatment of patients infected with highly resistant bacteria. Vancomycin is often considered the antiobiotic of last resort, if other antibiotics have failed to […]

Posted in | | Leave a response